- Exchange: EN Brussels
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Therapeutics
ThromboGenics NV
+ Add to WatchlistTHR:BB
34.3500 EUR 2.8100 7.56%As of 11:35:53 ET on 05/17/2013.
Company Profile for ThromboGenics NV (THR)
ThromboGenics NV is a biopharmaceutical company focused on the development of therapeutics for conditions related to the vascular system. The Company is focused on developing medicines to treat visual disorders, cardiovascular diseases, and cancer, conditions which result from abnormalities to the vascular system.
Contact Information
ThromboGenics NV
Gaston Geenslaan 1
B-3001
Heverlee
Belgium
Key Executives for ThromboGenics NV (THR)
| Desire CollenChairman/Founder | Patrik De HaesCEO/Executive Director |
| Chris BuyseCFO/Executive Director/Secy | Koen KasChief Scientific Officer |
| David PearsonHead:Country Operations | Andy De DeeneHead:Program Mgmt |
| Aniz GirachHead:Clinical Ophthalmology | Ram PalankiHead:Marketing |
| Laurence RaemdonckHead:Human Resources | Christian JaeggiHead:Country Operations |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Advertisements
Rate this Page